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Abstract: 
 
 
 
Zinc is essential for a wide variety of cellular processes in all cells. It is a critical dietary nutrient, 
particularly in the early stages of life. In the early neonatal period, adequate sources of zinc can be 
obtained from breast milk. In rare circumstances, the mammary gland produces zinc deficient milk 
that is potentially lethal for exclusively breast-fed infants. This can be overcome by zinc 
supplementation to the infant. Alterations to key zinc transporters provide insights into the 
mechanisms of cellular zinc homeostasis. The bioavailability of zinc in food depends on the 
presence of constituents that may complex zinc. In many countries, zinc deficiency is a major health 
issue due to poor nourishment. Young children are particularly affected. Zinc deficiency can impair 
immune function and contributes to the global burden of infectious diseases including diarrhoea, 
pneumonia and malaria. Furthermore, zinc deficiency may extend its effects across generations by 
inducing epigenetic effects that alter the expression of genes. This review discusses the significance 
of adequate zinc nutrition in infants, factors that influence zinc nutrition, the consequences of zinc 
deficiency, including its contribution to the global burden of disease and addresses some of the 
knowledge gaps in zinc biology. 
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Introduction 
Infancy is a critical phase of life that requires adequate nutrition to sustain growth and development. 
Pioneers in the field of zinc biology identified many years ago that at birth, a neonate has only small 
pools of metabolically available zinc, as evidenced by early onset growth failure in conditions of 
zinc restriction, despite the presence of normal tissue zinc levels [1].  Thus establishing the zinc 
requirements for infants has been of great importance.  This chapter discusses the importance of 
zinc nutrition, sources of dietary zinc and its bioavailability, requirements for mineral 
supplementation, risk factors for zinc deficiency, the effects of zinc deficiency and its contribution 
to the global burden of disease. The consequences of mutations and epigenetic changes to key zinc 
transporters provide insights into the cellular mechanisms regulating zinc homeostasis that are of 
particular importance to the health and development of infants and young children.  
 
Essentiality of zinc  
Zinc has many diverse roles in biological processes. At the cellular and molecular level, zinc is 
required for the structural and catalytic function of hundreds of enzymes that regulate the major 
metabolic pathways of the body [2].  As a structural component of transcription factors [3], zinc has 
a key role in regulation of gene expression and is involved in signal transduction and neuronal 
transmission [4, 5]. Numerous cellular processes require zinc including cell proliferation, 
differentiation, apoptosis and the integrity of cellular membranes  [6-9]. Zinc is essential for normal 
growth and development, for the immune response, and for cognitive function [10-12]. 
  
Nutrition and body zinc status 
The concept of body zinc status is based on the notion of acquisition of zinc that is sufficient for 
optimal biological processes. Body zinc status may be a consequence of dietary zinc intake, phytate 
consumption, gastrointestinal health, rate of zinc excretion and reabsorption, and other factors, 
many of which are not clear [13]. As there are numerous biological functions of zinc, many 
measures of zinc status have been considered, including zinc levels blood, urine, hair, feces, sweat, 
and saliva [14]. No single body zinc compartment represents an adequate estimate of overall body 
zinc status [1, 15, 16].  The WHO/UNICEF/IAEA/IZCG bodies recommend the use of three 
indicators to assess zinc status at the population level: prevalence of intakes below the estimated 
average requirement, percentage of low serum zinc concentrations and percentage of children less 
than 5 years who are stunted (WHO/UNICEF/IAEA/IZCG [17] and reviewed in [14]. The 
development of better indicators for zinc status is a major future challenge in the field of zinc 
biology. 
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In term infants the reference range for serum zinc in (10 to 17 µmol/L) is similar to that of healthy 
adults.  Zinc levels are generally highest at birth and gradually decrease to 4 months postpartum and 
then subsequently stabilizing at median levels [18-21].  The reference range for preterm infants at 
birth (74-146mcg/dL: 11-22 µmol/L) [22] is higher than that of normal term infants at birth, but 
progressively declines over the subsequent 6-12 weeks, correlating with rapid infant growth [23]. 
  
Dietary zinc requirements of infants 
Dietary requirements for essential nutrients including zinc provide estimates of whether intakes are 
adequate for optimal body function. The RDA (recommended dietary allowance) is the daily intake 
amount of a nutrient that is considered to be sufficient to meet the requirements of 97.5% of healthy 
individuals over the age of 6 months. RDAs for zinc vary between different countries and range 
from 1.5 to 2 mg/day for 0-6 months of age, 3-8 mg/day for 7-12 months of age and 4-9 mg/day for 
1-3 year olds [24]. Due to the demand for zinc in the growing infant, in relation to body size, the 
RDA for infants is greater than adults (for Australia the zinc RDA is 14mg/day for men and 
8mg/day for women [25]. The RDA for premature babies is 0.4 to 0.5 mg/kg/day [22]. More 
accurate estimates of RDA will be made possible with improved indicators of zinc status. 
 
Zinc in human breast milk and infant formulas 
Neonates are born with a substantial storage of zinc (25% of total body zinc) bound primarily to 
metallothioneins in the liver that accumulate in the last trimester of gestation [26-28]. These hepatic 
zinc reserves are progressively reduced until they reach the constant level at approximately 4 
months of age [28, 29]. However, unlike iron and copper, the major source of zinc in the neonatal 
period is breast milk [29].  The zinc concentration in human milk is highest in colostrum 
(approximately 8 mg/L) and then rapidly declines during the first week of lactation reaching 50% of 
initial concentration by day 7 of lactation. After the first week the decline in milk zinc concentration 
continues but is slower, reaching approximately 2 mg/L by 2 months, 1 mg/L by 6 months and 
dropping to about 0.5 mg/L by 12 months (summarised in [29-31].  For breast fed neonates, zinc 
concentrations in milk are considered to be adequate for the first 6 months of life but beyond that, 
despite an increase in the volume of milk consumed, zinc in breast milk is likely to be marginally 
adequate in the absence of a weaning diet (reviewed in [13, 30, 32].  
 
For premature infants, the level of zinc in breast milk cannot compensate for the increased zinc 
demand of the premature neonate due to higher than normal zinc requirements, the small size of 
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liver with reduced zinc storage and a short gastrointestinal system [22, 29, 30, 33-35]. These factors 
put premature infants in negative zinc balance until approximately 2 months of age and necessitates 
the use of zinc supplementation from birth [29, 36]. 
 
The WHO recommends exclusive breastfeeding of infants until 6 months of age (WHO Infant and 
young children nutrition resolution [37]). Despite the range of benefits that breast feeding offers for 
growing infants, only 16% of the infants in USA are exclusively breastfed at 6 months of age [38]. 
The remainder of infants are either exclusively formula-fed or receive a combination of formulas 
and breast milk [13]. The zinc content of formula milk ranges from 0.11 – 0.57 mg/100ml  [39]. 
The most common infant formulas used around the world are either cow’s milk-based formulas or 
soy-based formulas. Zinc bioavailability from any of the formulas is lower than from human breast 
milk, even though formulas often contain the higher concentration of zinc than breast milk. 
Therefore, to reach recommended dietary allowance for infants, formula zinc supplementation is 
commonly practiced [39-49]  
 
Zinc bioavailability in infant’s diet  
Stable isotope studies and zinc loading tests show that human milk has a greater zinc bioavailability 
than cow’s milk and infant formulas [40, 41]. Zinc absorption in healthy adults was on average 41% 
from human milk, 28% from cow’s milk, 31% from casein-based formula and only 14% from soy 
based formula [40]. A higher fractional absorption of zinc from human milk (54%) was found in 
infants [50]. An important factor in zinc bioavailability is the whey-to-casein ratio as zinc is more 
bioavailable from whey compared to casein [51-53]. In early lactation, human milk contains 
approximately 20% casein, and the whey-to-casein ratio is 80:20.  This is the opposite to the cow’s 
whey-to-casein ratio of 20:80. At the later stages of human lactation the whey-to-casein ratio 
changes to approximately 60:40 [54]. Zinc that is bound to casein is less bioavailable compared 
with zinc bound to whey proteins because micelles of highly phosphorylated casein in cow’s milk 
strongly bind zinc, making it less bioavailable to infants [31]. In early infancy, a large proportion of 
casein consumed from cow’s milk remains undigested and thus still binds zinc, possibly due to the 
low stomach acid secretion that results in incomplete digestion of the protein [31, 55, 56]. Human 
milk contains a lower concentration of casein than cow’s milk and has less zinc-binding phosphate 
groups on casein, thus only 15% of total milk zinc is bound to casein [57]. In human adults, zinc 
absorption from a casein-predominant milk formula was significantly lower than from a whey-
predominant formula [51].  
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Approximately 85% of zinc in human milk is bound to whey proteins, low-molecular-weight 
ligands and fat globules [57]. The main components of whey proteins in human milk that bind zinc 
are serum albumin, α-lactalbumin and possibly lactoferrin. [58, 59]. The major milk protein α-
lactalbumin which comprises 20-25% of total milk proteins binds zinc, and may facilitate its 
absorption [59]. Lactoferrin may also be a major zinc-binding protein from which zinc is absorbed 
[53], although another study reported that lactoferrin could only bind zinc in vitro at high zinc 
concentrations [57, 60].  
 
Human milk contains a number of low-molecular-weight factors including peptides, amino acids 
and growth factors. Of these, a major zinc binding ligand was identified to be citrate. Citrate is an 
efficient zinc chelator and binds approximately 23% of the zinc associated with low molecular mass 
ligands in milk [61]. The addition of citrate to milk formulas had a positive effect on zinc 
absorption in suckling rats [62].  
 
Dietary factors influencing zinc nutrition in infants 
Micronutrient interactions can affect zinc bioavailability and absorption. This can be through 
competition of transport processes or through zinc chelation. Iron supplements may interfere with 
zinc absorption [63, 64]. Cadmium can inhibit zinc absorption while some amino acids including 
histidine and methionine increase zinc absortion [65]. Dietary zinc bioavailability is influenced by 
many food constituents including phytate, a plant ligand of inositol phosphate that is present in 
cereals and legumes [66]. Phytate is a form in which phosphorus is stored in cereals, legumes and 
other plants. Phytates form poorly soluble complexes with zinc that reduce zinc absorption [67]. 
  
Vegetarianism 
Meat and seafood are major sources of dietary zinc, while the zinc in plant-based diets containing 
folate, fibre and phytochemicals, is less available [68]. Although grains, nuts and seeds can provide 
amounts of zinc similar to those found in animal tissues, adult populations with vegetarian diets 
have been found to have low zinc intakes [69-72] and in some cases reduced serum zinc levels [73]. 
Other studies on adults show no effects of vegetarian diets on serum zinc [70, 72, 74]. In young 
vegetarians, no differences in serum zinc between vegetarians and omnivores have been found [75]. 
  
Less information is available on zinc intakes and serum levels of infants and children who are 
vegetarians. National surveys in the United States estimate that  0.7 % of children aged 6 to 12 
years are vegetarians and 1% of children in New Zealand between 5 to 14 years are vegetarians 
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while 2% of children in the UK and Australia are vegetarian (see Foster and Samman 2014 for a 
review [67]. In the Australian study, there were no differences in plasma zinc levels in children 1.5-
4.5 years between vegetarians and omnivores, suggesting that adequate zinc is being provided by 
vegetarian diet [67]. In a review of zinc status of vegetarian and non-vegetarian children, no 
differences in serum zinc levels were seen in the three studies that were carried out [67]. However, 
on the basis of the lower zinc bioavailability in plants compared to animals, and the higher demand 
for zinc during growth, zinc supplementation has been recommended for vegetarian infants 
compared with non-vegetarians infants [67, 73, 75].  
  
Effect of maternal zinc status on infant health 
Although 82% of all pregnant women worldwide are estimated to be zinc deficient [76], zinc levels 
in human milk were found to be unrelated to maternal zinc status as measured by maternal plasma 
zinc levels [77], and the zinc status of the lactating mother does not influence transfer of zinc into 
milk [78-85].  Additionally, the majority of studies show no correlation between maternal age, 
parity or smoking habits on zinc levels in milk [78, 86-94].  
Maternal factors, however, may play an important role in influencing the health of the subsequent 
generation, from infancy onwards. Mice studies carried out by Hurley and Keen in the 1980s have 
shown a contribution of maternal zinc deficiency to changes, later identified as epigenetic changes, 
adversely affect the next generation [95, 96]. Persistent effects of zinc deficiency have been 
observed across generations. Offspring of mice fed a zinc-deficient diet (60-70% of the control 
dietary zinc) from day 7 of gestation showed reduced levels of IgM. The reduced IgM levels 
persisted into the subsequent second and third generations of animals despite a zinc-replete diet. 
There were no overt signs of zinc deficiency in the zinc-deprived dams [97]. Cross-fostering of the 
offspring from zinc-deprived animals did not ameliorate some of the immunoglobulin 
abnormalities. Significantly, this demonstrates the importance of maternal nutrition to the health of 
subsequent generations.  In humans, zinc deficiency during pregnancy has effects on the immune 
system of the fetus and reduces the size of the thymus and spleen and impairs the function of 
lymphocytes and neutrophils of the infant [98]. Maternal factors including age and BMI can affect 
subsequent generations through epigenetic mechanisms of which DNA methylation is a key process 
[99]. DNA methylation of zinc transporter gene ZnT5 was inversely correlated with length of 
gestation [99] providing evidence of maternal epigenetic effects on the subsequent generation. Zinc 
treatment increased histone H3 and H4 protein levels in cultured human neuronal cells providing a 
mechanism for the alteration of global gene expression levels [100]. A challenge in this area is to 
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understand how zinc deficiency during pregnancy influences the immune function of subsequent 
generations, including the early stages of life. 
 
Zinc deficiency in infants 
Zinc deficiency is a prevalent condition in countries with poor nourishment and particularly affects 
infants and young children. Due to the numerous roles of zinc in cell growth, differentiation and 
function and the lack of body stores, the infant is particularly susceptible to the adverse effects of 
zinc deficiency. Zinc deficiency accounts for the deaths of over half a million infants and children 
under 5 years of age, per year [13].  The WHO estimates that 800,000 deaths per year are due to 
zinc deficiency and that 50% of these are infants under the age of 5 years. [13]. Zinc deficiency 
contributes to the global burden of infectious disease through reducing immune function.  Zinc 
deficiency in children aged less than 5 years old increases the incidence of diarrhoeal disease by 
1.28, pneumonia by 1.52 and malaria by 1.56 [101, 102]. Based on these data zinc deficiency has 
been estimated to cause 176,000 diarrheal deaths, 406,000 pneumonia deaths and 207,000 malaria 
deaths. A recent analysis estimated the total mortality due to zinc deficiency to be 97,330 with a 
DALY of 9.14 million, ranking zinc deficiency 31st of the common risk factors contributing to the 
global burden of disease [103]. 
 
Cells with a rapid rate of turnover such as those of the immune, gastrointestinal systems, and skin 
are particularly vulnerable to zinc deficiency, accounting for the initial effects of dermatitis, 
diarrhoea, alopecia and loss of appetite [104, 105]. Severe zinc depletion for one month leads to 
hair, skin and mucous membrane changes, weight loss and growth retardation [13] that can become 
fatal in newborns [32]. Zinc deficiency impairs both the specific and the non-specific immune 
system that results in increased susceptibility to bacterial, viral and fungal pathogens [106]. 
  
At a population level, zinc deficiency is recognized as a public health problem.  In 1961 in Iran 
children with dwarfism, hypogonadism, hepatosplenomegaly, dry skin and mental lethargy were 
described [107]. These features were later found to be caused by zinc deficiency and resolved 
following zinc supplementation [108]. Higher rates of infectious diseases including skin infections, 
diarrhea, respiratory infections and malaria were also noted [109].  
  
Persistent mild to moderate zinc deficiency leads to growth stunting, poor appetite, impaired taste 
and smell, irritability and decrease resistance to infections [10, 102]. This type of zinc deficiency 
develops in infants usually due to the decline of zinc content in human milk [90, 110]. Infants who 
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are at risk of zinc deficiency include older exclusively breastfed infants, infants with low zinc 
intakes, premature and low birth weight infants, and those with diseases that impair gastrointestinal 
absorption [111, 112]. A number of diseases may predispose individuals to zinc deficiency, 
including untreated coeliac disease, Crohn’s disease, bowel conditions, and diarrhoea [13]. 
Symptoms of zinc deficiency are non-specific and this may lead to a lack of recognition of this 
problem. Mild zinc deficiency may pass undetected due to the lack of specific biomarkers [111] and 
in industrialised countries, identification of marginal zinc deficiency may be pertinent due to its 
insidious nature and the consumption of processed foods. In future, increased knowledge of the 
molecules involved in maintenance of zinc homeostasis may lead to the development of tests for 
marginal zinc deficiency that is a consequence of poor nutrition or other factors. This could be 
particularly important for detecting zinc deficiency in infants prior to the development of the 
clinical features of zinc deficiency. 
    
Zinc supplementation   
Preterm babies represent approximately about 12% of births in USA, and have a higher risk of 
micronutrient deficiency than term babies [113]. Zinc fortification of this group has been 
recommended [114]. Preterm babies are recommended to have zinc supplements ranging from 200-
500 µg/kg/day for infants born between 27 to 40 weeks gestation [22]. Very low birthweight 
premature infants, less than 1.5 kg at birth are recommended to have supplementation of 10 mg 
Zn/day beginning at week 1 until 42 weeks postpartum [115]. Maternal zinc supplementation of 
breastfeeding mothers is not considered as an effective treatment as it does not affect milk zinc 
levels [116]. 
  
Interventions to reduce zinc deficiency can have a huge impact on reducing the global burden of 
disease. Zinc supplementation reduces childhood mortality in countries where malnutrition and 
micronutrient deficiencies are prevalent [117]. As diarrhea and pneumonia are the two most 
common causes of childhood deaths in developing countries, zinc supplements are one of the 
proposed methods for reducing childhood mortality [118]. Analysis of zinc supplementation trials 
shows success in reduction of diarrhea and pneumonia at the population level [10, 102, 119]. Zinc 
supplementation reduced the prevalence of diarrhea by 25% and the incidence of pneumonia by 
41% [120]. Evidence suggests that zinc supplementation also reduces childhood mortility [102, 
121]. A systematic review of 20 independent intervention trials where zinc supplementation (5-50 
mg/day was provided to pregnant women showed a small decrease in risk of pre-term birth [122].  
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Genetic conditions in infants that are associated with zinc deficiency 
The most frequently occurring form of zinc deficiency is due to nutritional insufficiency.  Rarer 
forms of zinc deficiency that are inherited may be found in exclusively breast-fed babies, who 
present with symptoms characteristic of nutritional zinc deficiency, including dermatitis, diarrhoea, 
alopecia, loss of appetite, impaired immune function and neuropsychiatric changes [109, 123]. This 
type of zinc deficiency (transient neonatal zinc deficiency) is caused by reduced levels of zinc in the 
milk and is found more commonly in pre-term babies (27 to 33 weeks gestation), compared to term 
babies [123-130]. Zinc levels in the milk of such zinc-deficient breast fed babies can be less than 
90% that of normal milk at matched weeks of lactation [127, 128, 131] and it was established that 
maternal zinc deficiency was not the cause for the low zinc levels in breast). This form of neonatal 
zinc deficiency is most likely due to the higher zinc requirements of premature babies who also 
have a reduced capacity to absorb zinc from their gut [132]. In term infants however, the etiology of 
the transient zinc deficiency is not well understood, although a genetic component has recently been 
revealed. 
  
Twenty four zinc transporter genes belonging to two main families, SLC30A and SLC39A have been 
identified [133]. The protein products of these genes are membrane-spanning molecules, many of 
which have been demonstrated to mediate zinc transport. Fourteen members of SLC39 or ZIP 
family [134] and ten members of the ZnT family have been identified in mammalian cells [135]. 
Genetic studies have established that the neonatal zinc deficiency caused by reduced zinc levels in 
human milk is linked to mutations in SLC30A2 (ZnT2).  Different mutations have been found in 
SLC30A2.  These include a missense mutation that substituted a conserved histidine, at amino acid 
54, with arginine (H54R) [136] and a glycine to arginine substitution (G87R) [137] that reduced 
zinc concentrations in milk by more than 75%. Reductions in milk zinc levels to below 90% of 
normal were found associated with missense mutations where a tryptophan residue substituted for 
an arginine residue (W152R), and where a serine residue substituted for a leucine residue (S296L) 
[131].  Other studies have reported non-synonymous variations and polymorphisms in 
ZnT2/SLE30A2 that correlated with zinc levels in milk. In milk collected from a population of 54 
exclusively breast feeding mothers, non-synonymous variations in SLC30A2 were found in 36% of 
women, which were associated with variations in milk zinc concentrations  [138]. In vitro 
characterization indicated that some of these variants showed inappropriate cellular localization and 
altered subcellular zinc localization. In a another study of 750 breastfeeding women, variations in 
the milk zinc levels were associated with polymorphisms in SLC30A2 found in 9.7% of women, 
including -697G>T in the NF-1/L regulatory region of the SLC30A2 promotor, that may reduce its 
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transcription to cause low milk zinc levels. Additionally, two polymorphisms in the SLC30A2 
coding region lysine substituted for arginine (K344R) or for leucine substituted by proline (L23P) 
were associated with low levels of zinc in milk [139]. The L23P substitution was previously 
described to cause mislocalisation of the SLC30A2 protein to lysosomes instead of secretory 
endosomes, thus potentially affecting zinc secretion in mammary cells [140]. Thus genetic 
variations in ZnT2 may have consequences for infant growth and development by influencing the 
transport of zinc into milk.  
  
Other cases of neonatal zinc deficiency due to reduced levels of zinc in human milk are linked to 
reduced expression of two other zinc transporters, SLC30A5 and SLC30A6. In these cases 
SLC30A5 and SLC30A6 protein levels in white blood cells isolated from women with infants 
afflicted with neonatal zinc deficiency were reduced compared to cells isolated from non-affected 
women. Analysis of the promoter regions of the SLC30A5 and SLC30A6 genes revealed cell-
specific epigenetic changes between affected and unaffected mothers. In maternal lymphoblasts, 
CpG site 2 in SLC30A5 was significantly less methylated in affected mothers with compared with 
unaffected mothers while in maternal fibroblasts CpG site 2 in SLC30A5 was significantly more 
methylated.  Thus modified expression of SLC30A5 may account for the reduced activity of 
SLC30A5 and low levels of zinc in milk [141]. 
 
Further studies are required to clarify the specific cellular roles of all the family members of the 
zinc transporters in zinc homeostasis in growth and development. Greater knowledge of the genetic 
and epigenetic variants of zinc transporters in different tissues and how these impact on zinc 
homeostasis is essential, particularly in organs such as the mammary gland and the gut that play key 
roles in the delivery of nutrients. Such information will provide insights into how such variants 
impact on growth and development during infancy. Knowledge of the precise cellular function of 
zinc transporters may lead to the development of novel markers to assess zinc status.  
 
A murine disorder termed ‘lethal milk’ has a phenotype similar to the human condition including a 
30% reduction in milk zinc levels, where newborn pups nursed on homozygous mutant lethal milk 
dams develop lethal zinc deficiency within a week and die [142]. A defect in the secretion of zinc 
from the murine mammary gland was demonstrated [143, 144], and later linked to a mutation in 
another zinc transporter SLC30A4 [145].  Mutations in SLC30A4 were not found in several cases of 
neonatal zinc deficiency in humans [132], indicating that human and mouse conditions while 
having some phenotypic similarities, have different underlying causes. 
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Alternatively, zinc deficiency may result from impaired zinc absorption in the gut, as in 
acrodermatitis enteropathica (AE)[123]. Patients with AE were subsequently shown to have 
reduced intestinal absorption and intestinal secretion of zinc [146, 147]. This disorder usually 
develops after weaning as the zinc in human milk is more bioavailable than from other food sources 
[148].  AE is the most commonly described inherited form of zinc deficiency, first reported in 1902 
[149] and later described in more detail [150]. The symptoms of AE are similar to nutritional zinc 
deficiency and include skin lesions, alopecia, diarrhoea, neuropsychological disturbances, reduced 
immune function and death of patients in the absence of treatment [105]. AE was first identified as 
a zinc deficiency disease following successful resolution of symptoms with oral zinc 
supplementation [151]. Zinc replacement therapy commencing at 3 mg/kg/d of elemental zinc is 
recommended [152]. 
  
Diagnosis of AE may be problematic. The disease is rare and the characteristic erythematous rash is 
not confined to AE and may occur in other dermatological conditions [153]. Symptoms of zinc 
deficiency due to nutritional problems occur in digestive, pancreatic or hepatic diseases, and AE-
like disorders can be a consequence of deficiencies of other nutrients including amino acids and in 
metabolic disorders ([153]. 
  
Generally, the plasma levels of zinc in patients with AE who are untreated, are reduced (ranging 
from 0.33µmol/L to 8.1µmol/L) [154-159] however normal (11.5-22.5µmol/L) [154, 160] and 
higher (23.2µg/g dry weight relative to normal 10.4-11.9µg/g dry weight) [161] serum zinc levels 
have been reported. AE is successfully treated with 1-3mg/day of elemental zinc that results in the 
resolution of symptoms within days or weeks [141]. 
  
Defects in the SLC39A4 gene were identified as being responsible for AE [162, 163]. Deletions or 
insertions, premature terminations, frameshifts, splice-site defects, and polymorphisms in the 
promoter region of the gene account for 41 mutations or variants of ZIP4 reported in patients with 
the disorder [164]. The hZIP4 gene is expressed in the small intestine, stomach, colon and kidney 
[162], accounting for the reduced zinc absorption.  In some patients with symptoms of AE, no 
defects in SLC39A4 have been found suggesting other causes of this disease, possibly defects in 
other zinc transporters [165]. The genetic defects in the zinc transporters that result in zinc 
deficiency indicate the importance of zinc transporters in normal zinc homeostasis. 
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In conclusion, zinc is critical for infant growth and development. Zinc deficiency is a major global 
health issue that particularly affects young children and contributes to the global burden of 
infectious diseases including diarrhoea, pneumonia and malaria. As zinc is essential for immune 
function, its deficiency is a key factor in the increased susceptibility to infection found in states of 
nutritional deficiency.  Mutations in zinc transporter genes provide insights into the mechanisms of 
cellular zinc homeostasis. There is also evidence that zinc deficiency induces epigenetic effects that 
may affect subsequent generations. Future research is needed to clarify the functions of the 
SLC30A and SLC39A family members as well as other potential zinc transporters, in health and 
disease states, and to develop better markers for assessment of zinc status. 
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Figure legends: 
 
Fig 1.  Zinc-deficient infant born at 37 weeks gestation, showing necrolytic rash at lumbar and anal 
regions with blistering and desquamation 
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• Zinc is critical for infant growth and development 
• Zinc nutrition depends on zinc bioavailability  
• Zinc deficiency is a major global health issue that affects young children  
• Alterations in zinc transporters can cause zinc-deficient breast milk 
 
